ABBOTT LABORATORIES (ABT) Stock Fundamental Analysis

NYSE:ABT • US0028241000

112.68 USD
+1.21 (+1.09%)
At close: Feb 13, 2026
112.299 USD
-0.38 (-0.34%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Overall ABT gets a fundamental rating of 6 out of 10. We evaluated ABT against 186 industry peers in the Health Care Equipment & Supplies industry. While ABT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ABT is not valued too expensively and it also shows a decent growth rate. Finally ABT also has an excellent dividend rating. These ratings would make ABT suitable for dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year ABT was profitable.
  • In the past year ABT had a positive cash flow from operations.
  • ABT had positive earnings in each of the past 5 years.
  • Of the past 5 years ABT 4 years had a positive operating cash flow.
ABT Yearly Net Income VS EBIT VS OCF VS FCFABT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 16.60%, ABT belongs to the top of the industry, outperforming 97.31% of the companies in the same industry.
  • The Return On Equity of ABT (27.43%) is better than 98.39% of its industry peers.
  • ABT's Return On Invested Capital of 8.88% is amongst the best of the industry. ABT outperforms 88.71% of its industry peers.
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROIC 8.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABT Yearly ROA, ROE, ROICABT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With an excellent Profit Margin value of 31.88%, ABT belongs to the best of the industry, outperforming 98.39% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ABT has grown nicely.
  • ABT has a Operating Margin of 18.29%. This is amongst the best in the industry. ABT outperforms 89.78% of its industry peers.
  • In the last couple of years the Operating Margin of ABT has grown nicely.
  • ABT has a Gross Margin (56.19%) which is comparable to the rest of the industry.
  • ABT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
ABT Yearly Profit, Operating, Gross MarginsABT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • ABT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for ABT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ABT Yearly Shares OutstandingABT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABT Yearly Total Debt VS Total AssetsABT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 5.30 indicates that ABT is not in any danger for bankruptcy at the moment.
  • ABT has a Altman-Z score of 5.30. This is amongst the best in the industry. ABT outperforms 80.11% of its industry peers.
  • ABT has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
  • ABT has a Debt to FCF ratio of 1.87. This is amongst the best in the industry. ABT outperforms 88.17% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that ABT is not too dependend on debt financing.
  • The Debt to Equity ratio of ABT (0.23) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Altman-Z 5.3
ROIC/WACC0.92
WACC9.61%
ABT Yearly LT Debt VS Equity VS FCFABT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.70 indicates that ABT should not have too much problems paying its short term obligations.
  • ABT has a worse Current ratio (1.70) than 68.28% of its industry peers.
  • ABT has a Quick Ratio of 1.24. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
  • ABT has a worse Quick ratio (1.24) than 65.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.24
ABT Yearly Current Assets VS Current LiabilitesABT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ABT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
  • Measured over the past 5 years, ABT shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • The Revenue has been growing slightly by 5.67% in the past year.
  • The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • ABT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.18% yearly.
  • Based on estimates for the next years, ABT will show a small growth in Revenue. The Revenue will grow by 7.15% on average per year.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.18%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.15%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABT Yearly Revenue VS EstimatesABT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B
ABT Yearly EPS VS EstimatesABT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 21.88 indicates a rather expensive valuation of ABT.
  • Based on the Price/Earnings ratio, ABT is valued cheaper than 81.18% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.97, ABT is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 19.62, ABT is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, ABT is valued cheaper than 81.18% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ABT to the average of the S&P500 Index (27.96), we can say ABT is valued slightly cheaper.
Industry RankSector Rank
PE 21.88
Fwd PE 19.62
ABT Price Earnings VS Forward Price EarningsABT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ABT is valued a bit cheaper than 76.88% of the companies in the same industry.
  • 80.65% of the companies in the same industry are more expensive than ABT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 28.33
EV/EBITDA 17.83
ABT Per share dataABT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of ABT may justify a higher PE ratio.
PEG (NY)1.9
PEG (5Y)3.07
EPS Next 2Y10.76%
EPS Next 3Y10.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.31%, ABT has a reasonable but not impressive dividend return.
  • ABT's Dividend Yield is rather good when compared to the industry average which is at 0.20. ABT pays more dividend than 97.31% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.79, ABT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

  • The dividend of ABT is nicely growing with an annual growth rate of 11.40%!
  • ABT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ABT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.4%
Div Incr Years34
Div Non Decr Years34
ABT Yearly Dividends per shareABT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 28.93% of the earnings are spent on dividend by ABT. This is a low number and sustainable payout ratio.
  • The dividend of ABT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
ABT Yearly Income VS Free CF VS DividendABT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABT Dividend Payout.ABT Dividend Payout, showing the Payout Ratio.ABT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABBOTT LABORATORIES

NYSE:ABT (2/13/2026, 8:04:00 PM)

After market: 112.299 -0.38 (-0.34%)

112.68

+1.21 (+1.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.33%
Inst Owner Change-1.33%
Ins Owners0.45%
Ins Owner Change0.04%
Market Cap195.94B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts79.43
Price Target136.02 (20.71%)
Short Float %1.15%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly Dividend2.21
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-15
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-7.35%
PT rev (3m)-7.37%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.16%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)-0.63%
Valuation
Industry RankSector Rank
PE 21.88
Fwd PE 19.62
P/S 4.47
P/FCF 28.33
P/OCF 21.49
P/B 3.85
P/tB 9.16
EV/EBITDA 17.83
EPS(TTM)5.15
EY4.57%
EPS(NY)5.74
Fwd EY5.1%
FCF(TTM)3.98
FCFY3.53%
OCF(TTM)5.24
OCFY4.65%
SpS25.21
BVpS29.3
TBVpS12.3
PEG (NY)1.9
PEG (5Y)3.07
Graham Number58.27
Profitability
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROCE 11.52%
ROIC 8.88%
ROICexc 9.99%
ROICexgc 19.14%
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
FCFM 15.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Debt/EBITDA 1.04
Cap/Depr 70.33%
Cap/Sales 5.02%
Interest Coverage 250
Cash Conversion 81.77%
Profit Quality 49.49%
Current Ratio 1.7
Quick Ratio 1.24
Altman-Z 5.3
F-Score8
WACC9.61%
ROIC/WACC0.92
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.18%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.15%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.17%
EBIT Next 3Y13.91%
EBIT Next 5Y14.39%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A

ABBOTT LABORATORIES / ABT FAQ

What is the fundamental rating for ABT stock?

ChartMill assigns a fundamental rating of 6 / 10 to ABT.


What is the valuation status of ABBOTT LABORATORIES (ABT) stock?

ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.


What is the profitability of ABT stock?

ABBOTT LABORATORIES (ABT) has a profitability rating of 7 / 10.


What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 21.88 and the Price/Book (PB) ratio is 3.85.


Can you provide the expected EPS growth for ABT stock?

The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.5% in the next year.